Impact of Infections in Patients With Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax During Induction Chemotherapy. IJBR 2025, 3 (1), 190-196. https://doi.org/10.70749/ijbr.v3i1.469.